Abstract
Can existing unrelated vaccines boost a COVID-19 vaccine prime?
Highlights
Commentary—The development of new specific vaccines against COVID-19 has occurred as the US program name promised, at “warp speed,” and emergency use authorization has led to vaccine rollout around the world
Vaccination schedules are designed around specific trials and regimens, and the currently authorized COVID-19 vaccines have been developed with a booster dose scheduled a certain time after the initial prime
Economic and logistical considerations have motivated studies to assess one-dose compared to two-dose vaccines, and at least one ‘one-dose’ COVID-19 vaccine is under development
Summary
Can existing unrelated vaccines boost a COVID-19 vaccine prime? Commentary—The development of new specific vaccines against COVID-19 has occurred as the US program name promised, at “warp speed,” and emergency use authorization has led to vaccine rollout around the world. Most vaccinations require one or more “boosts” to reach a level of memory cells needed to provide protection against infection.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
